Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome

Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome

Cardiorenal syndrome (CRS) results from complex interaction between heart and kidneys, inducing simultaneous acute or chronic dysfunction of these organs. Although its incidence rate is increasing with higher mortality in patients, effective clinical treatment drugs are currently not available. The...

Full description

Bibliographic Details
Main Authors: Shuangcui Wang, Yuli Wang, Yun Deng, Jiaqi Zhang, Xijuan Jiang, Jianchun Yu, Jiali Gan, Wenyun Zeng, Maojuan Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Pharmacology
Subjects:
cardiorenal syndrome
sacubitril/valsartan
RAAS
NPS
research progress
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1167260/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1167260/full

Similar Items